Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

Probiotics Expressing GLP-1 as an Aid to prevent or Treat Diabetes


Detailed Technology Description

The technology provides recombinant cells and methodsusing commensal bacteria for the prevention and treatment of diabetes ormetabolic syndromes.


Others

  • Patents issued in the U.S. 8,771,668 (D-4291) and 9,265,842 (D-5208)
  • Patents issued in the Europe EP2274416 (D-4291) and EP2627770(D-5208)
  • Duan, F., Curtis, K. L. and March, J. C. (2008).Secreting insulinotropic proteins from commensal bacteria: rewiring the gut totreat diabetes. Applied and Environmental Microbiology, 74: 7437-7438
  • Duan,F., Liu, J. H. and March, J. C. (2015). Engineered commensal bacteria reprogram intestinal cells intoglucose-responsive insulin-secreting cells for the treatment of diabetes.  Diabetes, 64: 1794-1803.

  


Country/Region

USA

For more information, please click Here
Business of IP Asia Forum
Desktop View